Menu

Topics

Connect

Comments

Want to discuss? Please read our Commenting Policy first.

As vaccine rollout plans are finalized, U.S. prepares for worsening coronavirus surge

WATCH ABOVE: A special committee is set to approve the use of a COVID-19 vaccine across the United States later this week, with long-term care residents and first responders as the top priority for the first doses. But as Jennifer Johnson reports, officials warn that the worst is still yet to come. – Dec 6, 2020

Top U.S. health officials announced plans on Tuesday to begin vaccinating Americans against the coronavirus as early as mid-December, as nationwide deaths hit the highest number for a single day in six months.

Story continues below advertisement

Some 20 million people could be inoculated against COVID-19 by the end of 2020 and most Americans will have access to highly effective vaccines by mid-2021, the chief adviser of President Donald Trump’s Operation Warp Speed program said.

“Within 24 hours, maybe at most 36 to 48 hours, from the approval, the vaccine can be in people’s arms,” Moncef Slaoui, a former GlaxoSmithKline executive who is overseeing the vaccine portion of the U.S. program, said at an event conducted by The Washington Post.

Story continues below advertisement

His comments came on the same day that another 2,295 fatalities nationwide were linked to COVID-19, even before California, the most populous U.S. state, reported full results. Officials in several states said numbers were higher in part due to a backlog from the Thanksgiving holiday.

A statement from the public health director for Los Angeles County highlighted the ravages of the surging pandemic. Barbara Ferrer, the public health director, said that while Tuesday was the county’s “worst day thus far” of the pandemic, .”..it will likely not remain the worst day of the pandemic in Los Angeles County. That will be tomorrow, and the next day and the next as cases, hospitalizations and deaths increase.”

Health officials pleaded with Americans to stick with coronavirus restrictions even with a vaccine in sight.

Story continues below advertisement

The U.S. Centers for Disease Control and Prevention is moving to shorten the length of self-quarantine recommended after potential exposure to the coronavirus to 10 days, or seven days with a negative test, a federal spokesperson said on Tuesday. The CDC currently recommends a 14-day quarantine in order to curb the transmission of the virus.

Vaccine timeline

Some 60 million to 70 million doses of COVID-19 vaccine could be available per month beginning in January, after the expected regulatory approval of products from Pfizer Inc and Moderna Inc, Slaoui said.

A Food and Drug Administration panel of outside advisers will meet on Dec. 10 to discuss whether to recommend emergency use authorization of the Pfizer vaccine, developed with German partner BioNTech SE. Moderna’s vaccine candidate is expected to be reviewed a week later.

Story continues below advertisement

The timeline described by Slaoui and Health and Human Services Secretary Alex Azar appeared to assume that the FDA’s authorization of the first vaccine would come within days of the Dec. 10 meeting.

But the head of the FDA’s Center for Biologics Evaluation and Research, Dr. Peter Marks, told patient advocacy groups last week that it might take “a few days to a few weeks.”

FDA Commissioner Stephen Hahn, likewise, has said the process could take longer.

The U.S. Transportation Department said on Tuesday it has made preparations to enable the “immediate mass shipment” of COVID-19 vaccines and completed all necessary regulatory measures.

Story continues below advertisement

An estimated 21 million healthcare workers and 3 million residents of long-term care facilities should be first in line to receive a vaccine, according to a recommendation voted on by a CDC panel of advisers on Tuesday.

Nursing homes are experiencing the worst outbreak of weekly coronavirus cases since the spring, according to the American Health Care Association and National Center for Assisted Living (AHCA/NCAL).

Holiday travel spike

State and local officials have returned to imposing restrictions on businesses and activities in response to the latest surge of a pandemic that killed 37,000 people in November.

November’s toll was far lower than the 60,699 recorded in April but perilously close to the next-highest total of almost 42,000 in May, according to data compiled by Johns Hopkins University. Deaths had dropped to just over 20,000 in June after states closed many businesses and ordered people to stay at home.

Story continues below advertisement

The virus is blamed for over 268,000 deaths and more than 13.5 million confirmed infections in the United States. A record 96,000 people were in the hospital with the virus in the U.S. as of Monday. The U.S. is seeing on average more than 160,000 new cases per day and almost 1,470 deaths — equal to what the country was witnessing in mid-May.

 

Hospitalizations and deaths are expected to spike even higher during the holiday travel season, a trend that officials warn could overwhelm already strained healthcare systems.

The monthly death toll from COVID-19 is projected to nearly double in December to a pandemic-high of more than 70,000 and surpass 76,000 in January before ebbing in February, according to a widely cited model from the University of Washington’s Institute for Health Metrics and Evaluation.

Story continues below advertisement

Pandemic-related restrictions have ravaged the U.S. economy. A bipartisan group of U.S. lawmakers on Tuesday unveiled a $908 billion COVID-19 relief bill aimed at breaking a deadlock over emergency assistance for small businesses, industries and the unemployed.

(Reporting by Doina Chiacu and Julie Steenhuysen; Additional reporting by Lisa Shumaker, Maria Caspani, Peter Szekely, Jonathan Allen, David Shepardson, Steve Gorman and Dan Whitcomb; Writing by Daniel Trotta and Dan Whitcomb; Editing by Bill Berkrot, Bill Tarrant and Leslie Adler)

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article